S&P 500 · SPY
759.97
▼ -3.99 (-0.52%)
DOW JONES · DIA
521.37
▼ -6.52 (-1.24%)
NASDAQ · QQQ
704.40
▼ -0.07 (-0.01%)
GOLD · GLD
$366.61
▼ -2.39 (-0.65%)
OIL (WTI) · USO
$169.53
▲ +7.02 (+4.32%)
BITCOIN
$79,489.86
▼ -2,120.66 (-2.60%)
--:--:--
NYSE · Live ET

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

Summary from the CNBC news feed. Copyright belongs to CNBC.

Read full story at CNBC ↗

Opens in a new tab, so Investz stays open.

ShareEmailXLinkedInFacebookRedditWhatsApp

More headlines

All news
MarketWatchWalmart, Best Buy and other stores now use digital price tags. Critics say they could lead to different prices for different shoppers.CNBCAI funding fears rattle Wall Street. Here's how we're adjusting our portfolioMarketWatchRetire on 8% a year with little or no risk? How to use annuities the right way.MarketWatchMy partner of 17 years left me his $1 million home. His children are crying foul. Am I obliged to split it with them?CNBCAmerican embassies tighten security as Iran threat warnings intensify ahead of U.S. midterm electionsMarketWatchMoney-saving habits to cope with higher prices — from our readers

Headlines and summaries come from publishers’ public news feeds and are shown with attribution and a link to the original. Investz does not write or endorse them and they are not investment advice. Disclosures.